He, Ming-ming
Zhang, Dong-sheng
Wang, Feng
Wang, Zi-xian
Yuan, Shu-qiang
Wang, Zhi-qiang
Luo, Hui-yan
Ren, Chao
Qiu, Miao-zhen
Jin, Ying
Wang, De-shen
Chen, Dong-liang
Zeng, Zhao-lei
Li, Yu-hong
He, Yang-yang
Hao, Yuan-tao
Guo, Pi
Wang, Feng-hua
Zeng, Yi-xin
Xu, Rui-hua
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
https://doi.org/10.1007/s00280-016-3209-1
Article History
Received: 9 September 2016
Accepted: 24 November 2016
First Online: 2 December 2016
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: This study was approved by the independent Institute Research Ethics Committee at the Sun Yat-sen University Cancer Center and conducted in accordance with the Declaration of Helsinki. All patients signed informed consent before participation.